Facebook
Instagram
Linkedin
Twitter
Home
Podcasts
Video
Contact Us
Partnership
Search
Go
Search
Home
Podcasts
Video
Contact Us
Partnership
Go
Search
Home
Podcasts
Video
Contact Us
Partnership
New Research from The Vision Council Explores Consumer Behavior in Q3 2026
Drs. Glover & Lyerly
-
October 28, 2026
Press Release: 2026 Optical Advancement Grant
ESSILOR® REDEFINES ANTI-REFLECTIVE PERFORMANCE WITH CRIZAL®’S LEAST VISIBLE COATING*1
EssilorLuxottica and Meta Expand AI Glasses Portfolio with Ray-Ban Meta Optics Styles
Transitions Optical Announces Call for Education Grant Applications
In New Research from The Vision Council, Eyecare Providers Adapt to Tariffs and Inflation,...
Drs. Glover & Lyerly
-
March 6, 2026
Transitions® Opens 2026 With Updated Certification Program
Drs. Glover & Lyerly
-
March 4, 2026
EYECON Returns to New York City March 2026 — A Unique Show Platform Honoring...
Drs. Glover & Lyerly
-
October 27, 2025
LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States
Drs. Glover & Lyerly
-
September 30, 2025
Essilor Stellest is the first and only FDA market authorized spectacle lens in the...
Drs. Glover & Lyerly
-
September 25, 2025
LENZ Therapeutics Announces US FDA Approval of VIZZ™ for the Treatment of Presbyopia
Drs. Glover & Lyerly
-
August 2, 2025
Oakley has officially named Travis Scott as their first-ever Chief Visionary
Dr. Darryl Glover
-
June 25, 2025
Transitions Announces Winners of its Optical Advancement Educational Grants
Dr. Darryl Glover
-
June 3, 2025
Transitions ® Certification Program Updated with New Education Opportunities
Dr. Darryl Glover
-
May 1, 2025
New England College of Optometry Announces 2025 Honorary Degree Recipient, Award Winners, and Valedictorian
Drs. Glover & Lyerly
-
May 1, 2025
1
2
3
...
17
Page 1 of 17
